Daiichi Sankyo (PK) Quote - DSKYF

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

31.55

Bid

28.90

Ask

31.55

Volume

7,288

28.15 Day's Range 31.55

25.95 52 Week Range 44.64

Market Cap

60.475B

Previous Close

28.536

Open

28.31

Last Trade

30.525

Last Trade Time

Financial Volume

US$ 216,759

VWAP

29.742

Average Volume (3m)

3,463

Shares Outstanding

1,916,787,029

Dividend Yield

14,720.82%

PE Ratio

0.30

Earnings Per Share (EPS)

104.72

Revenue

1.63T

Net Profit

200.73B

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Biolog/vaccines

Website

www.daiichisankyo.co.jp

Headquarters

Chuo, Tokyo, Jpn

Founded

2005

Daiichi Sankyo Co Ltd (PK) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker DSKYF. The last closing price for Daiichi Sankyo (PK) was US$28.54. Over the last year, Daiichi Sankyo (PK) shares have traded in a share price range of US$ 25.95 to US$ 44.64.

Daiichi Sankyo (PK) currently has 1,916,787,029 shares outstanding. The market capitalization of Daiichi Sankyo (PK) is US$54.70 billion. Daiichi Sankyo (PK) has a price to earnings ratio (PE ratio) of 0.30.

Daiichi Sankyo's Once-Daily Lixiana® (edoxaban) Approved for the Prevention of Stroke and Systemic Embolism in Non-Valvular ...

Daiichi Sankyo's Once-Daily Lixiana® (edoxaban) Approved for the Prevention of Stroke and Systemic Embolism in Non-Valvular Atrial Fibrillation and for the Treatment and Prevention of Recurrent...

Daiichi Sankyo, Inc. and Asubio Pharmaceuticals, Inc. Merge

Daiichi Sankyo, Inc. and Asubio Pharmaceuticals, Inc. Merge PR Newswire PARSIPPANY, N.J., April 1, 2015 PARSIPPANY, N.J., April 1, 2015 /PRNewswire/ -- Daiichi Sankyo, Inc., the US subsidiary of...

Venue Change

Tue, Oct 08, 2013 12:00 - Daiichi Sankyo Co., Ltd. (DSKYF: OTC Link) - Venue Change - The symbol, DSKYF, no longer trades on Grey Market. As of Tue, Oct 08, 2013, DSKYF trades on OTC Link. You...

Glaxo Files for Two Flu Vaccines - Analyst Blog

Recently, GlaxoSmithKline (GSK) announced that it has filed marketing applications for two influenza vaccines. The vaccines, up for approval, include a quadrivalent influenza vaccine for the...

Glaxo and Daiichi to Set Up JV - Analyst Blog

British drugmaker GlaxoSmithKline (GSK) recently announced that it has signed an agreement with Daiichi Sankyo (DSKYF) to form a joint venture (JV). The JV will be called Japan Vaccine Co., Ltd...

Daiichi Sankyo, Inc. Names Danesha Dixon Smith Vice President of Human Resources

Daiichi Sankyo, Inc. Names Danesha Dixon Smith Vice President of Human Resources PR Newswire PARSIPPANY, N.J., June 28, 2011 PARSIPPANY, N.J., June 28, 2011 /PRNewswire/ -- Daiichi Sankyo, Inc...

John P. Gargiulo Named President and CEO of Daiichi Sankyo, Inc.

John P. Gargiulo Named President and CEO of Daiichi Sankyo, Inc. PR Newswire PARSIPPANY, N.J., April 4, 2011 PARSIPPANY, N.J., April 4, 2011 /PRNewswire/ -- Daiichi Sankyo, Inc. (DSI) announced...

Update: Daiichi Sankyo Completes Enrollment of the Edoxaban Global Phase III ENGAGE AF-TIMI 48 Study in Patients With Atrial Fib

Update: Daiichi Sankyo Completes Enrollment of the Edoxaban Global Phase III ENGAGE AF-TIMI 48 Study in Patients With Atrial Fibrillation - More Than 21,000 Patients Enrolled in the Largest...

Daiichi Sankyo Completes Enrollment of the Edoxaban Global Phase III ENGAGE AF-TIMI 48 Study in Patients With Atrial Fibrillatio

Daiichi Sankyo Completes Enrollment of the Edoxaban Global Phase III ENGAGE AF-TIMI 48 Study in Patients With Atrial Fibrillation - More Than 21,000 Patients Enrolled in the Largest Clinical...

ArQule and Daiichi Sankyo Expand Drug Discovery Collaboration in Oncology

ArQule and Daiichi Sankyo Expand Drug Discovery Collaboration in Oncology PR Newswire WOBURN, Massachusetts, October 12, 2010 WOBURN, Massachusetts, October 12, 2010 /PRNewswire/ -- ArQule, Inc...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	1.09	3.57846355877	30.46	33.09	27.15	6748	28.91900714	CS
4	0.39	1.25160462131	31.16	34.6	27.15	4578	30.91492183	CS
12	-6.89	-17.924037461	38.44	44.64	27.15	3463	33.52745314	CS
26	-4.33	-12.0680044593	35.88	44.64	27.15	5493	34.50607706	CS
52	4.99	18.7876506024	26.56	44.64	25.95	10196	31.65880671	CS
156	4.72	17.5922474842	26.83	44.64	19.45	8020	30.16840193	CS
260	-30.529411	-49.1779971946	62.079411	95.96	17.61	6189	30.10797516	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
PDROPedros List Inc (CE)	US$ 0.0032 (319,900.00%)	31.17k
GBXIGBX International Group Inc (CE)	US$ 0.0002 (19,900.00%)	1.53k
ATHCAccelerated Technologies Holding Corporation (CE)	US$ 0.0001 (9,900.00%)	173
MGTIMGT Capital Investments Inc (CE)	US$ 0.0001 (9,900.00%)	457.82k
TTCFQTattooed Chef Inc (CE)	US$ 0.0001 (9,900.00%)	54.21k
AGDXFAntioqua Gold Inc (CE)	US$ 0.000001 (-100.00%)	60k
FGHFFForte Group Holdings Inc (PK)	US$ 0.0007 (-99.82%)	343
IGFFFInfinito Gold Ltd (CE)	US$ 0.000001 (-99.80%)	15k
EGRNFChina Evergrande Group (CE)	US$ 0.000001 (-99.67%)	500
LLBOLifeline Biotech Inc (CE)	US$ 0.000001 (-99.67%)	1.01M
NSAVNet Savings Link Inc (PK)	US$ 0.00105 (31.25%)	173.45M
RDARRaadr Inc (PK)	US$ 0.0008 (33.33%)	172.18M
AITXArtificial Intelligence Technology Solutions Inc (PK)	US$ 0.0035 (2.94%)	165.17M
HMBLHUMBL Inc (PK)	US$ 0.0003 (0.00%)	146.21M
CBDLCBD Life Sciences Inc (PK)	US$ 0.0005 (25.00%)	125.1M